Interface Biologics Revenue and Competitors
Estimated Revenue & Valuation
- Interface Biologics's estimated annual revenue is currently $1.4M per year.
- Interface Biologics's estimated revenue per employee is $155,000
Employee Data
- Interface Biologics has 9 Employees.
- Interface Biologics grew their employee count by 0% last year.
Interface Biologics's People
Name | Title | Email/Phone |
---|
Interface Biologics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.2M | 27 | 29% | $5M | N/A |
#2 | $1.7M | 11 | 22% | N/A | N/A |
#3 | $0.9M | 11 | -72% | $39.4M | N/A |
#4 | $1M | 13 | -84% | $23.8M | N/A |
#5 | $94.4M | 609 | 8% | N/A | N/A |
#6 | $3.4M | 22 | 10% | N/A | N/A |
#7 | $9.5M | 61 | -68% | N/A | N/A |
#8 | $18.1M | 117 | 30% | N/A | N/A |
#9 | $21.7M | 140 | -6% | N/A | N/A |
#10 | $1M | 13 | -41% | N/A | N/A |
What Is Interface Biologics?
Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI's primary technology focus areas are anti-thrombogenic additives that reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery devices.Â
keywords:N/AN/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Interface Biologics News
Global Electrophysiology Laboratory Devices Market 2022 Industry Growth Abbott, Cardiorobotics, Interface Biologics, Meridian Health System.
Alere; Cardiorobotics; Interface Biologics; Meridian Health System; Cardiva Medical; Lombard Medical Technologies; Deltex Medical Group; Biotelemetry; Bioheart...
Alere Inc., Cardiorobotics Inc., Interface Biologics Inc., Meridian Health System Inc, Cardiva Medical Inc., Lombard Medical Technologies...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 9 | 0% | N/A |
#2 | $0.6M | 9 | 13% | N/A |
#3 | $0.7M | 9 | N/A | N/A |
#4 | $0.1M | 9 | -25% | $1.3M |
#5 | $0.7M | 9 | N/A | N/A |